TLDR
- UNH reports Q2 FY2026 earnings before market open on Thursday, July 16
- Wall Street expects EPS of $4.84–$4.85, up 18.6% year over year
- Revenue forecast sits at $110.05–$110.76 billion, down ~1.4% from a year ago
- Options traders are pricing in a 6.27% move in either direction post-earnings
- UNH stock is up roughly 30% year-to-date heading into the report
UnitedHealth Group is set to report its second-quarter 2026 results before the market opens on Thursday, July 16. The stock has already had a strong run in 2026, up around 30% year-to-date.
UnitedHealth Group Incorporated, UNH
Wall Street analysts are forecasting earnings per share of $4.84 to $4.85 for the quarter. That would be an increase of 18.6% compared to the same period last year.
On the revenue side, analysts expect the company to bring in approximately $110.05 billion to $110.76 billion. That would represent a decline of around 1.4% from Q2 2025.
Options traders are bracing for a notable reaction either way. According to TipRanks’ Options Tool, the market is pricing in a move of roughly 6.27% in UNH stock following the earnings release.
The Medical Care Ratio is one figure to watch closely. Analysts forecast it will come in at 88.6%, compared to 89.4% in the same quarter last year. A lower ratio generally means the company is spending less on medical costs relative to premiums collected.
Revenue Breakdown
On the revenue side, analysts have broken down their expectations across UNH’s business segments. Premium revenues are expected to hit $85.93 billion, down 2.2% year over year. Services revenue is projected at $9.55 billion, up 5.6% from a year ago.
Products revenue is seen at $13.68 billion, a 0.9% increase. Investment and other income is forecast at $1.03 billion, down 7.3%.
The growth in the Optum healthcare services segment has been a key driver of UNH’s strong stock performance this year, alongside premium rate increases and improving profit margins.
Membership Numbers in Focus
Analysts are also watching UNH’s customer count closely. Total domestic commercial members served are expected to come in at 29.53 million, down from 29.97 million a year ago.
Risk-based commercial members are projected to fall to 7.26 million from 8.44 million in Q2 2025. Fee-based commercial members, however, are expected to rise to 22.27 million from 21.53 million.
Total Community and Senior members are forecast at 18.70 million, down from 20.15 million last year. Medicare Advantage membership is expected at 7.43 million, compared to 8.35 million in the year-ago quarter.
Medicare Part D stand-alone membership is projected at 2.68 million, down from 2.80 million a year ago.
Consensus EPS estimates have held steady over the past 30 days, with no revisions from analysts covering the stock. That kind of stability ahead of earnings can sometimes signal that the Street feels reasonably confident in its projections — though the options market’s 6.27% implied move suggests investors aren’t taking anything for granted.
UnitedHealth last reported results in April, and the stock’s 30% year-to-date gain puts it in a position where the bar for impressing the market is higher than usual.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.






Be the first to comment